Literature DB >> 15390068

Distribution, type, and origin of Parkin mutations: review and case studies.

Katja Hedrich1, Cordula Eskelson, Beth Wilmot, Karen Marder, Juliette Harris, Jennifer Garrels, Helen Meija-Santana, Peter Vieregge, Helfried Jacobs, Susan B Bressman, Anthony E Lang, Martin Kann, Giovanni Abbruzzese, Paolo Martinelli, Eberhard Schwinger, Laurie J Ozelius, Peter P Pramstaller, Christine Klein, Patricia Kramer.   

Abstract

Early-onset Parkinson's disease (PD) has been associated with different mutations in the Parkin gene (PARK2). To study distribution and type of Parkin mutations, we carried out a comprehensive literature review that demonstrated two prominent types of mutations among 379 unrelated mutation carriers: exon rearrangements involving exon 3, 4, or both, and alterations in exons 2 and 7, suggesting mutational hot spots or founders. To elucidate the origin of 14 recurrent Parkin mutations in our samples, we carried out a detailed haplotype analysis at the PARK2 locus. Thirty-eight mutation-positive individuals, available family members, and 62 mutation-negative individuals were genotyped. We determined allele frequencies and linkage disequilibrium (LD) to evaluate the significance of shared haplotypes. We observed no LD between markers at PARK2. Our data support a common founder for the most frequent Parkin point mutation (924C>T; exon 7) and indicate a mutational hot spot as cause of a common small deletion (255/256delA; exon 2). Furthermore, the most frequent Parkin exon deletion (Ex4del) arose independently in 2 of our subjects. However, it also occurred as the result of a founder mutation in 2 cases that shared identical deletion break points. This study provides evidence for both mutational hot spots and founder mutations as a source of recurrent mutations in Parkin, regardless of the mutation type. (c) 2004 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15390068     DOI: 10.1002/mds.20234

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  60 in total

1.  Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.

Authors:  Hsin F Chien; Christan F Rohé; Maria D L Costa; Guido J Breedveld; Ben A Oostra; Egberto R Barbosa; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2005-11-22       Impact factor: 2.660

Review 2.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

3.  Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.

Authors:  Hee Jin Kim; Han-Joon Kim; Jee-Young Lee; Ji Young Yun; So Yeon Kim; Sung Sup Park; Beom S Jeon
Journal:  J Neurol       Date:  2011-05-29       Impact factor: 4.849

4.  Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism.

Authors:  Ji-feng Guo; Xue-wei Zhang; Li-luo Nie; Hai-nan Zhang; Bin Liao; Jing Li; Lei Wang; Xin-xiang Yan; Bei-sha Tang
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

Review 5.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

6.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.

Authors:  L N Clark; B M Ross; Y Wang; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

7.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Debbie Lombard; Rene Veikondis; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2009-12-15       Impact factor: 2.660

8.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

9.  Hotspots of large rare deletions in the human genome.

Authors:  W Edward C Bradley; John V Raelson; Daniel Y Dubois; Eric Godin; Hélène Fournier; Charles Privé; René Allard; Vadym Pinchuk; Micheline Lapalme; René J A Paulussen; Abdelmajid Belouchi
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

10.  DNA damage induces nuclear translocation of parkin.

Authors:  Shyan-Yuan Kao
Journal:  J Biomed Sci       Date:  2009-07-17       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.